Gene And Cell Therapy Products Community

 View Only
Back to discussions
Expand all | Collapse all

FDA Hosting Townhall on Clinical Development of Gene Therapy Products for Rare Diseases

  • 1.  FDA Hosting Townhall on Clinical Development of Gene Therapy Products for Rare Diseases

    Community Leadership
    Posted 01-19-2023 13:33
    Greetings All,

    This Townhall may be relevant to multiple Communities including Gene & Cell Therapy Products, Regulatory, Biomarkers, PPDM, CMC, etc.:

    The FDA's Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to the clinical development of gene therapy products for rare diseases (excluding hematology/oncology products). This event is part of a series to answer questions from stakeholders about a variety of topics on which OTAT has regulatory oversight.

    Meeting Logistics

    For more information and registration:  OTAT Town Hall: Clinical Development of Gene Therapy Products for Rare Diseases - 02/07/2023 | FDA

    Best Regards,
    Steven-

    ------------------------------
    Steven Louie M.S.
    Sr. Principal Scientist
    Novartis
    Cambridge MA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------